LEE KENNETH B JR 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Sep 15, 2021
Insider Transaction Report
Form 4
LEE KENNETH B JR
Director
Transactions
- Sale
Common Stock
2021-09-13$15.35/sh−6,000$92,100→ 24,252 total - Exercise/Conversion
Common Stock
2021-09-13$3.22/sh+15,000$48,300→ 30,252 total - Exercise/Conversion
Automatic Stock Option Grant
2021-09-13−15,000→ 0 totalExercise: $3.32From: 2012-06-23Exp: 2022-05-23→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.24 to $15.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.